You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The grants were awarded as part of Australia's Genomics Health Futures Mission, which was launched in 2018 as part of a broader health research initiative.
Using a single-nucleus RNA sequencing strategy, investigators tracked down cell type-specific gene expression and networks in Alzheimer's brains.
An Australian research team found that population genetic screening for hereditary cancer and for carrier status could be cost-effective.
An Australian team has sequenced some 4,000 healthy individuals over 70 years old for the Medical Genome Reference Bank database.
It will be possible to upload genomic data to Australia's My Health Record system, which has raised privacy issues, the Sydney Morning Herald reports.
The researchers focused on modeling a signaling pathway that they believe could be a viable target for combination therapies that they hope to explore in clinical trials.
In PLOS this week: study of genetic compensation in zebrafish, workflow to identify molecular changes, and more.
BC Platforms will provide Monash with its core suite of tools including ones for statistical analysis, variant interpretation, and data sharing.
Agilent will provide technology and training for the jointly-run lab, expanding on a 2011 deal to open a microarray technology center at Monash University Malaysia.
The single-cell genomics center at the Monash Health Translation Precinct near Melbourne will be the first of its kind in Australia.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.